• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药代动力学因素作为非甾体抗炎药反应变异性的原因

Pharmacokinetic factors as causes of variability in response to non-steroidal anti-inflammatory drugs.

作者信息

Brune K

出版信息

Agents Actions Suppl. 1985;17:59-63. doi: 10.1007/978-3-0348-7720-6_7.

DOI:10.1007/978-3-0348-7720-6_7
PMID:3879100
Abstract

Even the most widely used non-steroidal anti-inflammatory drugs (NSAID's) show considerable variations in their pharmacokinetic behaviour in volunteers and moreso in patients. An evaluation of the response-related pharmacokinetic parameters of the three presently most widely used NSAID's, namely diclofenac, indomethacin and piroxicam shows some obvious reasons: While the onset of absorption and the bioavailability of diclofenac varies considerably, we find relevant differences in the terminal plasma half-life of indomethacin and particularly piroxicam. Inter-patient variability in these parameters may contribute significantly to the observed variations in clinical response.

摘要

即使是最广泛使用的非甾体抗炎药(NSAID)在志愿者中的药代动力学行为也存在相当大的差异,在患者中更是如此。对目前最广泛使用的三种NSAID(即双氯芬酸、吲哚美辛和吡罗昔康)的反应相关药代动力学参数进行评估,发现了一些明显的原因:虽然双氯芬酸的吸收起始和生物利用度差异很大,但我们发现吲哚美辛尤其是吡罗昔康的终末血浆半衰期存在相关差异。这些参数在患者间的变异性可能是导致观察到的临床反应差异的重要原因。

相似文献

1
Pharmacokinetic factors as causes of variability in response to non-steroidal anti-inflammatory drugs.药代动力学因素作为非甾体抗炎药反应变异性的原因
Agents Actions Suppl. 1985;17:59-63. doi: 10.1007/978-3-0348-7720-6_7.
2
Clinical relevance of nonsteroidal anti-inflammatory drug pharmacokinetics.非甾体抗炎药药代动力学的临床相关性。
Eur J Rheumatol Inflamm. 1987;8(1):18-23.
3
[Transsynovial kinetics and correlation of dosage and effect of non-steroidal anti-rheumatic agents].[非甾体类抗风湿药的经滑膜动力学及剂量与效应的相关性]
Fortschr Med. 1982 Sep 23;100(36):1642-6.
4
Non-steroidal and analgesic therapy in the elderly.
Clin Rheum Dis. 1986 Apr;12(1):245-73.
5
The effect of activated charcoal on the bioavailability of piroxicam in man.
Int J Clin Pharmacol Ther Toxicol. 1986 Jan;24(1):48-52.
6
Pharmacokinetic observations on piroxicam in young adult, middle-aged and elderly patients.吡罗昔康在青年、中年和老年患者中的药代动力学观察。
Br J Clin Pharmacol. 1983 Oct;16(4):433-7. doi: 10.1111/j.1365-2125.1983.tb02191.x.
7
[Kidney function in therapy with non-steroidal antiphlogistic drugs. A double-blind cross-over study with diclofenac, indomethacin and piroxicam].[非甾体抗炎药治疗中的肾功能。双氯芬酸、吲哚美辛和吡罗昔康的双盲交叉研究]
Z Rheumatol. 1991 Nov-Dec;50(6):366-70.
8
Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.非甾体抗炎药的临床药代动力学
Clin Pharmacokinet. 1983 Jul-Aug;8(4):297-331. doi: 10.2165/00003088-198308040-00003.
9
[Stomach tolerance of non-steroid anti-rheumatic agents. Studies on gastric irritation caused by carprofen in comparison with acetylsalicyclic acid, indomethacin, piroxicam, and diclofenac].[非甾体类抗风湿药的胃耐受性。与阿司匹林、吲哚美辛、吡罗昔康和双氯芬酸相比,卡洛芬引起的胃刺激研究]
Fortschr Med. 1982 Sep 23;100(36):1661-8.
10
Pharmacokinetics of piroxicam, a new nonsteroidal anti-inflammatory agent, under fasting and postprandial states in man.新型非甾体抗炎药吡罗昔康在人体禁食和餐后状态下的药代动力学
J Pharmacokinet Biopharm. 1979 Aug;7(4):369-81. doi: 10.1007/BF01062535.

引用本文的文献

1
Bidirectional interactions between indomethacin and the murine intestinal microbiota.吲哚美辛与小鼠肠道微生物群之间的双向相互作用。
Elife. 2015 Dec 23;4:e08973. doi: 10.7554/eLife.08973.
2
Classical absorption theory and the development of gastric mucosal damage associated with the non-steroidal anti-inflammatory drugs.经典吸收理论与非甾体抗炎药相关胃黏膜损伤的发展
Arch Toxicol. 1987 Jun;60(4):261-9. doi: 10.1007/BF01234664.